TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9248765

Group type: EXPERIMENTAL
Intervention: Oestradiol valerate (4 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone (40 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Oral placebo
Number of subjects: 9
Study: 1945609

Group type: EXPERIMENTAL
Intervention: Acute Illness Observation Scales (AIOS)
Number of subjects: 369

Group type: COMPARATOR
Intervention: Three-point global assessment scale (Control)
Number of subjects: 369
Study: 6807679

Group type: EXPERIMENTAL
Intervention: Thiotepa
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: VM26
Number of subjects: 308

Group type: COMPARATOR
Intervention: Control (TUR only)
Number of subjects: 308
Study: 31095257

Group type: EXPERIMENTAL
Intervention: eFACE scores of the palpebral fissure at rest before eyelid weight placement (84.3 [15.9]) vs after (109.7 [21.4])
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: eFACE scores with gentle eyelid closure before eyelid weight placement (65.9 [28.0]) vs after (92.1 [15.4])
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: eFACE scores with forceful eyelid closure before eyelid weight placement (75.1 [28.6]) vs after (97.0 [10.7])
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Emotrics measurements of palpebral fissure at rest before eyelid weight placement (10.3 [2.2]) vs after (9.1 [1.8])
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Emotrics measurements with gentle eyelid closure before eyelid weight placement (4.4 [2.7]) vs after (1.3 [2.0])
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Emotrics measurements with forceful eyelid closure before eyelid weight placement (3.0 [3.1]) vs after (0.5 [1.3])
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Subgroup analysis of patients with expected recovery (n=40) showed eFACE scores before (83.9 [22.7]) vs after (98.9 [4.4]) eyelid weight placement
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Subgroup analysis of patients with no expected recovery (n=13) showed improvement in both eFACE and Emotrics analysis after eyelid weight placement
Number of subjects: 53
Study: 27317436

Group type: EXPERIMENTAL
Intervention: Galaxy COPD model
Number of subjects: 0
Study: 25959707

Group type: EXPERIMENTAL
Intervention: Kinesio Taping (KT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control
Number of subjects: 36
Study: 23928295

Group type: EXPERIMENTAL
Intervention: ∆9-tetrahydrocannabinol (THC)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 21333272

Group type: EXPERIMENTAL
Intervention: Culturally adapted CBT (CA-CBT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Applied muscle relaxation (AMR)
Number of subjects: 24
Study: 19896184

Group type: EXPERIMENTAL
Intervention: Routine strategy for chest radiographs
Number of subjects: 849

Group type: COMPARATOR
Intervention: On-demand strategy for chest radiographs
Number of subjects: 849
Study: 17126768

Group type: EXPERIMENTAL
Intervention: Lactobacillus fermentum 2 capsules twice daily (2 x 10^9 CFU per capsule) for 10 weeks
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46

Group type: COMPARATOR
Intervention: Lactobacillus fermentum and Placebo
Number of subjects: 46
Study: 14972339

Group type: EXPERIMENTAL
Intervention: Visual Analogue Scale (VAS)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Categorical Scale (CT)
Number of subjects: 73
Study: 11303192

Group type: EXPERIMENTAL
Intervention: Minimal criteria for pelvic inflammatory disease (CDC recommendations)
Number of subjects: 651

Group type: EXPERIMENTAL
Intervention: Adnexal tenderness
Number of subjects: 651

Group type: EXPERIMENTAL
Intervention: Positive test result for Chlamydia trachomatis or Neisseria gonorrhoeae
Number of subjects: 651

Group type: EXPERIMENTAL
Intervention: Combinations of clinical criteria
Number of subjects: 651
Study: 9850033

Group type: EXPERIMENTAL
Intervention: Lenograstim 2 microg/kg daily
Number of subjects: 52

Group type: COMPARATOR
Intervention: Lenograstim 5 microg/kg daily
Number of subjects: 52
Study: 7826820

Group type: EXPERIMENTAL
Intervention: Nebivolol
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Nebivolol with L-NMMA infusion
Number of subjects: 11

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Nebivolol with PGF2 alpha preconstriction
Number of subjects: 11
Study: 3400680

Group type: EXPERIMENTAL
Intervention: Higher dose regimen: 5 g mezlocillin plus 2 g cefoperazone intravenously every four hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lower dose regimen: 3 g mezlocillin plus 1 g cefoperazone intravenously every four hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher dose regimen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lower dose regimen
Number of subjects: 0
Study: 28844431

Group type: EXPERIMENTAL
Intervention: NAVIGATE (coordinated specialty care intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: CC (usual community care)
Number of subjects: 0
Study: 26650226

Group type: EXPERIMENTAL
Intervention: Web-based questionnaire (WBQ)
Number of subjects: 128

Group type: COMPARATOR
Intervention: No questionnaire (Control)
Number of subjects: 128
Study: 25769911

Group type: EXPERIMENTAL
Intervention: BI 655066 (any dose)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 23796210

Group type: EXPERIMENTAL
Intervention: 100 kVp with hybrid iterative reconstruction algorithm level of 40% (i-100 kVp)
Number of subjects: 110

Group type: COMPARATOR
Intervention: 120 kVp with hybrid iterative reconstruction algorithm level of 60% (i-120 kVp)
Number of subjects: 110
Study: 20097781

Group type: EXPERIMENTAL
Intervention: Balance/strength training for 6 weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (age-matched subjects)
Number of subjects: 16
Study: 18174457

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 3986

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3986
Study: 16758238

Group type: EXPERIMENTAL
Intervention: Diazepam (10 mg)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Methylphenidate (40 mg)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 12751880

Group type: EXPERIMENTAL
Intervention: School-based preventive intervention (Botvin, G. J. 1996, 2000)
Number of subjects: 847
Study: 11192620

Group type: EXPERIMENTAL
Intervention: Active rTMS (20 2s 20 Hz stimulations at 80% motor threshold over 20 min, dorsolateral prefrontal cortex)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 12
Study: 8752198

Group type: EXPERIMENTAL
Intervention: Transdermal scopolamine
Number of subjects: 0
Study: 8447207

Group type: EXPERIMENTAL
Intervention: Glucose solution before surgery and Ringer‐acetate during surgery
Number of subjects: 14

Group type: COMPARATOR
Intervention: No glucose before and during surgery (starved)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Glucose before surgery and Ringer‐acetate during surgery
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Ringer‐acetate alone or Ringer‐acetate plus 10% glucose
Number of subjects: 14
Study: 3510947

Group type: EXPERIMENTAL
Intervention: Terlipressin
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 28389851

Group type: EXPERIMENTAL
Intervention: Mean Difference (MD)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Nonoverlap of All Pairs (NAP)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Percentage of Nonoverlapping Data (PND)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Restricted Randomized Alternation Design (RRAD)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Completely Randomized Design (CRD)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Randomized Block Design (RBD)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Simulated Data Types
Number of subjects: 20
Study: 27615039

Group type: EXPERIMENTAL
Intervention: Assertiveness training applying Dongsasub training (4 sessions)
Number of subjects: 63
Study: 25007405

Group type: EXPERIMENTAL
Intervention: Rapid Response Team (RRT) intervention
Number of subjects: 286

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 286
Study: 23512256

Group type: EXPERIMENTAL
Intervention: Umesh's intubation detector
Number of subjects: 100
Study: 20628312

Group type: EXPERIMENTAL
Intervention: Injection of hypertonic saline-epinephrine (HSE) solution (1 mL) 1 to 2-cm oral to the papilla
Number of subjects: 120

Group type: COMPARATOR
Intervention: No injection (noninjection group)
Number of subjects: 120
Study: 17938425

Group type: EXPERIMENTAL
Intervention: Paclitaxel 200 mg/m2 on day 1 plus gemcitabine 1 gm/m2 on days 1 and 8 (arm A)
Number of subjects: 512

Group type: COMPARATOR
Intervention: Carboplatin at AUC of 6 mg on day 1 plus gemcitabine 1 gm/m2 on days 1 and 8 (arm B)
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Overall Survival (OS)
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: 1-year survival
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Objective Response (OR)
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Time to Progression (TtP)
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Toxicity
Number of subjects: 512
Study: 17002741

Group type: EXPERIMENTAL
Intervention: Post-operative oral care including tooth brushing, denture cleaning, and tongue cleaning
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (only gargled with povidone iodine)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Post-operative oral care
Number of subjects: 30
Study: 12728025

Group type: EXPERIMENTAL
Intervention: Maximal activation of knee muscles in female athletes
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Sports involving jumping and pivoting maneuvers
Number of subjects: 52
Study: 10801169

Group type: EXPERIMENTAL
Intervention: Structured attention
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Self-hypnotic relaxation
Number of subjects: 241

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 241
Study: 8633674

Group type: EXPERIMENTAL
Intervention: CUSA 200 cavitational ultrasonic surgical aspirator (group 1, 20 patients)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No CUSA (group 2, 20 patients)
Number of subjects: 40
Study: 1425524

Group type: EXPERIMENTAL
Intervention: Basal diet supplemented with 76 mumol (5 mg) Zn/kg diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Basal diet supplemented with 153 mumol (10 mg) Zn/kg diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Basal diet alone
Number of subjects: 0
Study: 6480851

Group type: EXPERIMENTAL
Intervention: Easy client
Number of subjects: 31

Group type: COMPARATOR
Intervention: Difficult client
Number of subjects: 31
Study: 30900659

Group type: EXPERIMENTAL
Intervention: Xylitol chewing gum (1.1 g each, 2 pieces daily for 14 days)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Sorbitol chewing gum (1.1 g each, 2 pieces daily for 14 days)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no gum)
Number of subjects: 48
Study: 29190507

Group type: EXPERIMENTAL
Intervention: M-EI regimen (7 M-courses and 2 EI-courses)
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: M-EI regimen
Number of subjects: 409
Study: 27421061

Group type: EXPERIMENTAL
Intervention: Implicit alcohol approach tendencies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implicit alcohol avoidance tendencies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implicit alcohol approach and avoidance tendencies
Number of subjects: 0
Study: 25265132

Group type: EXPERIMENTAL
Intervention: OXN PR 20-120mg/day for 12 weeks (non-cancer pain) or 4 weeks (cancer-related pain)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: OXN PR 20-120mg/day
Number of subjects: 75
Study: 22518944

Group type: EXPERIMENTAL
Intervention: Ankle taping (closed basket weave technique)
Number of subjects: 26

Group type: COMPARATOR
Intervention: No ankle taping (control condition)
Number of subjects: 26
Study: 20064275

Group type: EXPERIMENTAL
Intervention: Constraint Induced Movement Therapy (CIMT)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Bimanual Training (BIM training)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: CIMT
Number of subjects: 52

Group type: COMPARATOR
Intervention: BIM training
Number of subjects: 52
Study: 18691988

Group type: EXPERIMENTAL
Intervention: aranidipine 5 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: aranidipine 10 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: aranidipine 20 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: aranidipine 10 mg (multiple doses)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: M-1 metabolite (aranidipine 10 mg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: M-1 metabolite (aranidipine 5 mg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: M-1 metabolite (aranidipine 20 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study: 15673502

Group type: EXPERIMENTAL
Intervention: Vancomycin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metronidazole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Newer treatment strategies
Number of subjects: 0
Study: 12422155

Group type: EXPERIMENTAL
Intervention: 8-cm coil catheter
Number of subjects: 26

Group type: COMPARATOR
Intervention: 5.5-cm coil catheter
Number of subjects: 26
Study: 10527297

Group type: EXPERIMENTAL
Intervention: Special intervention (brief physician- and nurse practitioner-delivered counseling)
Number of subjects: 530

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 530
Study: 7562757

Group type: COMPARATOR
Intervention: Methotrexate
Number of subjects: 10

Group type: COMPARATOR
Intervention: Global assessments and skin scores
Number of subjects: 10
Study: 2189450

Group type: EXPERIMENTAL
Intervention: General anesthesia
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia
Number of subjects: 19
Study: 772827

Group type: EXPERIMENTAL
Intervention: Penicillin 50,000 U/kg/d and Kanamycin 10 mg/kg/d
Number of subjects: 51

Group type: COMPARATOR
Intervention: Non-treatment group
Number of subjects: 51
Study: 31942889

Group type: EXPERIMENTAL
Intervention: Cu resistance clones from metagenomic libraries
Number of subjects: 411

Group type: COMPARATOR
Intervention: Cu-sensitive E. coli strain (ΔCopA)
Number of subjects: 411
Study: 31699631

Group type: EXPERIMENTAL
Intervention: Educational video on third molar extraction
Number of subjects: 100
Study: 28279506

Group type: EXPERIMENTAL
Intervention: TOPYPS scale
Number of subjects: 67
Study: 26332338

Group type: EXPERIMENTAL
Intervention: Wii-based Movement Therapy
Number of subjects: 41

Group type: COMPARATOR
Intervention: modified Constraint-induced Movement Therapy
Number of subjects: 41
Study: 23645374

Group type: EXPERIMENTAL
Intervention: PureVision SH lenses with Alcon Opti‐Free Express solution
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: PureVision SH lenses with Renu Fresh solution
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (non-lens wearers)
Number of subjects: 25
Study: 21590284

Group type: EXPERIMENTAL
Intervention: Methylphenidate (10, 20, and 40 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 19892235

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg/day
Number of subjects: 5011

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5011
Study: 16374781

Group type: EXPERIMENTAL
Intervention: PDL (Pulsed Dye Laser)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: LPDL (Long Pulsed Dye Laser)
Number of subjects: 52

Group type: COMPARATOR
Intervention: PDL
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: LPDL
Number of subjects: 52
Study: 15226172

Group type: EXPERIMENTAL
Intervention: Peak probability contrast method
Number of subjects: 0
Study: 10642014

Group type: EXPERIMENTAL
Intervention: Geriatric Evaluation and Management (GEM)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 128
Study: 9155284

Group type: EXPERIMENTAL
Intervention: Catheter valves (seven types available on the UK market in April 1996) tested for 1 week
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Catheter valves (same types) tested for ease of opening/closing
Number of subjects: 36
Study: 8444070

Group type: EXPERIMENTAL
Intervention: Metronidazole (400 mg twice a day)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Misoprostol (200 micrograms four times a day)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Indomethacin (50 mg three times a day)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (no drug regimen)
Number of subjects: 16
Study: 3707170

Group type: EXPERIMENTAL
Intervention: Collagen matrix
Number of subjects: 20

Group type: COMPARATOR
Intervention: Monsel's solution
Number of subjects: 20
Study: 30497420

Group type: EXPERIMENTAL
Intervention: Periodized circuit training
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Educational protocol
Number of subjects: 60
Study: 27394051

Group type: EXPERIMENTAL
Intervention: In My Shoes (IMS) interview
Number of subjects: 54

Group type: COMPARATOR
Intervention: Forensic best practice interview
Number of subjects: 54
Study: 24127265

Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT)
Number of subjects: 1050
Study: 22784474

Group type: EXPERIMENTAL
Intervention: Cisatracurium stored at room temperature (0.15mg/kg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cisatracurium stored at +4°C (0.15mg/kg)
Number of subjects: 30
Study: 21174751

Group type: EXPERIMENTAL
Intervention: Drug treatment combined with hyperbaric oxygen therapy (HBOT) for two weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Drug treatment alone for two weeks
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Drug treatment combined with HBOT
Number of subjects: 120

Group type: COMPARATOR
Intervention: Drug treatment alone
Number of subjects: 120
Study: 19012813

Group type: EXPERIMENTAL
Intervention: Triple-bead mixed amphetamine salts (starting dose 12.5 mg)
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Triple-bead mixed amphetamine salts
Number of subjects: 272

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 272
Study: 15869337

Group type: EXPERIMENTAL
Intervention: Empirically supported treatments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized controlled trials
Number of subjects: 0
Study: 12563460

Group type: EXPERIMENTAL
Intervention: Proximal gastric vagotomy (PGV)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Anterior lesser curve seromyotomy with posterior truncal vagotomy (ASPTV)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ligature of short gastric vessels with PGV or ASPTV
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Comparison of SpO2 in proximal lesser curve and gastric fundus vs gastric corpus
Number of subjects: 20
Study: 10635188

Group type: EXPERIMENTAL
Intervention: Implant supported FPDs (two implants)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Tooth-implant supported FPDs (one implant and one tooth)
Number of subjects: 23
Study: 8942319

Group type: EXPERIMENTAL
Intervention: Questioners rating past behaviors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Answerers rating past behaviors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prediction of future performance in a quiz-game setting
Number of subjects: 0
Study: 1758244

Group type: EXPERIMENTAL
Intervention: Clonidine (1 ml, 0.15 mg) with 3 ml 0.5% hyperbaric bupivacaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline (3 ml 0.5% hyperbaric bupivacaine plus 1 ml normal saline)
Number of subjects: 40
Study: 6215927

Group type: EXPERIMENTAL
Intervention: Zimelidine
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ethanol
Number of subjects: 8
Study: 30570527

Group type: EXPERIMENTAL
Intervention: Postpartum maternal ARVs
Number of subjects: 254

Group type: COMPARATOR
Intervention: Daily infant nevirapine
Number of subjects: 254
Study: 28218934

Group type: EXPERIMENTAL
Intervention: Precepting in the Presence of the Patient (PIPP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conference Room Staffing (CRS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PIPP
Number of subjects: 0
Study: 25661270

Group type: EXPERIMENTAL
Intervention: Acupuncture plus conventional analgesic treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional postoperative analgesic treatment
Number of subjects: 60
Study: 23399382

Group type: EXPERIMENTAL
Intervention: Nicotine patch (14 mg for smokers, 7 mg for non-smokers)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Standard trials
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Nicotine patch
Number of subjects: 48
Study: 21739685

Group type: EXPERIMENTAL
Intervention: Acupuncture-rehabilitation group
Number of subjects: 90

Group type: COMPARATOR
Intervention: Body acupuncture group
Number of subjects: 90

Group type: COMPARATOR
Intervention: Medication group
Number of subjects: 90
Study: 19657105

Group type: EXPERIMENTAL
Intervention: Transcranial sonography (TCS)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control subjects (healthy subjects)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Larger bilateral SN echogenic area
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Small SN echogenic area (SN hypoechogenicity)
Number of subjects: 75
Study: 16368659

Group type: EXPERIMENTAL
Intervention: Self-reported craving scores after exposure to a heroin-related cue
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Physiological measures of craving after exposure to a heroin-related cue
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Subjective and physiological cue reactivity
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Relation between subjective and physiological cue reactivity
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Moderation effect of social desirability on the relation between subjective and physiological reactivity
Number of subjects: 76
Study: 12215608

Group type: EXPERIMENTAL
Intervention: Intracerebral hemorrhage patients
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 46
Study: 11220541

Group type: EXPERIMENTAL
Intervention: 4-of-7 mode-switching algorithm
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 1-of-1 mode-switching algorithm
Number of subjects: 17

Group type: COMPARATOR
Intervention: standard mode-switching algorithm
Number of subjects: 17